Live from the NIH registry
Studies recruiting near Naperville right now
Top 25 of 2,361 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Advocate Children's Hospital-Oak Lawn — Oak Lawn, Illinois (21.2 mi)
· Sponsor: National Cancer Institute (NCI)
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
University of Chicago Medicine-Orland Park — Orland Park, Illinois (18.0 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
University Illinois Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: Westat
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Northwestern University — Chicago, Illinois (27.5 mi)
· Sponsor: Medtronic MiniMed, Inc.
Forceps vs. Snare IVC Filter Removal
DVT
N/A
Interventional 100 participants sought
UChicago Medicine — Chicago, Illinois (27.5 mi)
· Sponsor: University of Chicago
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Overactive Bladder (OAB), Urinary Urgency
N/A
Interventional 596 participants sought
University of Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: Medstar Health Research Institute
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Rush University Medical Center — Chicago, Illinois (27.5 mi)
· Sponsor: Relay Therapeutics, Inc.
Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement
Healthy Adult
N/A
Interventional 34 participants sought
Biofortis Clinical Research — Addison, Illinois (15.6 mi)
· Sponsor: Shaklee Corporation
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
Northwestern — Chicago, Illinois (27.5 mi)
· Sponsor: Tr1X, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Arlington Heights, Illinois (25.4 mi)
· Sponsor: AstraZeneca
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0), Albuminuria
Phase 2
Interventional 20 participants sought
University of Illinois Chicago, Sickle Cell Center — Chicago, Illinois (27.5 mi)
· Sponsor: University of Illinois at Chicago
Moon and Sun Brothers: A Community Prevention Intervention (Hermanos de Luna y Sol)
Help-Seeking Behavior, Pre-exposure Prophylaxis Use
N/A
Interventional 360 participants sought
Chicago Queer Latine Collaborative — Chicago, Illinois (27.5 mi)
· Sponsor: San Francisco State University
Analysis of Human ALS Tissues and Registry of ALS Patients
Amyotrophic Lateral Sclerosis
N/A
Observational 40 participants sought
University of Illinois at Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: University of Illinois at Chicago
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
Liver Diseases
N/A
Observational 1,200 participants sought
The University of Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: University of Chicago
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Allergic Reactions
Phase 4
Interventional 600 participants sought
Endeavor Health — Glenview, Illinois (29.5 mi)
· Sponsor: ARS Pharmaceuticals, Inc.
Aromatherapy and Music Impact on Nurses' Stress at Work
Stress
N/A
Interventional 25 participants sought
Northwestern Medicine Academic Medical Center — Chicago, Illinois (27.5 mi)
· Sponsor: Northwestern University
Oxygenation in Vascular Lesions of the Colon
Vascular Lesion
N/A
Interventional 30 participants sought
University of Chicago — Chicago, Illinois (27.5 mi)
· Sponsor: University of Chicago
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Orchard Healthcare Research Inc. — Skokie, Illinois (29.7 mi)
· Sponsor: Regeneron Pharmaceuticals
Pupillometry in Delayed Sleep Wake Phase Disorder
Delayed Sleep-Wake Phase Disorder
N/A
Interventional 220 participants sought
Northwestern University — Chicago, Illinois (27.5 mi)
· Sponsor: Northwestern University
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Obesity
Phase 3
Interventional 600 participants sought
Endeavor Health — Skokie, Illinois (29.7 mi)
· Sponsor: Novo Nordisk A/S
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Northwestern Medicine Cancer Center Warrenville — Warrenville, Illinois (4.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
University of Chicago Medicine — Chicago, Illinois (27.5 mi)
· Sponsor: Takeda
A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
Acute Leukemia, Lymphoblastic Leukemia
Phase 1, Phase 2
Interventional 15 participants sought
University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois (27.5 mi)
· Sponsor: University of Chicago
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Hinsdale, Illinois (12.3 mi)
· Sponsor: AstraZeneca
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
University Retina and Macula Associates, PC — Lemont, Illinois (9.9 mi)
· Sponsor: Genentech, Inc.